Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Northeast Pharmaceutical Group Co's
Operating Income
for the
three
months ended in Jun. 2026 was ¥84 Mil. Northeast Pharmaceutical Group Co's Interest Expense for the
three
months ended in Jun. 2026 was ¥-9 Mil.
Northeast Pharmaceutical Group Co's interest coverage for the quarter that ended in Jun. 2026 was 9.63.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Northeast Pharmaceutical Group Co's Interest Coverage or its related term are showing as below:
SZSE:000597'
s Interest Coverage Range Over the Past 10 Years
Min: 1.34 Med: 3.21 Max: 10.28
Current: 9.4
SZSE:000597's Interest Coverage is ranked worse than 56.78% of 678
companies
in the Drug Manufacturers industry
Industry Median: 12.575
vs SZSE:000597: 9.40
Northeast Pharmaceutical Group Co (SZSE:000597) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Northeast Pharmaceutical Group Co Interest Coverage Related Terms
Northeast Pharmaceutical Group Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Northeast Pharmaceutical Group Co Interest Coverage Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Northeast Pharmaceutical Group Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Northeast Pharmaceutical Group Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Northeast Pharmaceutical Group Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Northeast Pharmaceutical Group Co's Interest Coverage falls into.
Northeast Pharmaceutical Group Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Northeast Pharmaceutical Group Co (SZSE:000597) has a Interest Coverage of 9.63 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Northeast Pharmaceutical Group Co and its competitors. This is 200% above median its historical median of 3.21. Over the past decade, Northeast Pharmaceutical Group Co's Interest Coverage has ranged from 1.34 to 10.28. According to the industry distribution chart, Northeast Pharmaceutical Group Co ranks #385 out of 678 companies in the Drug Manufacturers industry, placing it in the top 56.8%.
Is Northeast Pharmaceutical Group Co's Interest Coverage too high?
Northeast Pharmaceutical Group Co's current Interest Coverage of 9.63 is 200% above median its 10-year median of 3.21. Over the past 10 years, this metric has ranged from a low of 1.34 to a high of 10.28. The Drug Manufacturers industry median Interest Coverage is 12.58. Northeast Pharmaceutical Group Co's value of 9.63 is 23.4% below this industry median. Based on the distribution chart, Northeast Pharmaceutical Group Co ranks #385 out of 678 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Northeast Pharmaceutical Group Co has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Northeast Pharmaceutical Group Co's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Northeast Pharmaceutical Group Co ranks #385 out of 678 companies for Interest Coverage. This places Northeast Pharmaceutical Group Co in the lower half of its industry. The industry median Interest Coverage is 12.58. Northeast Pharmaceutical Group Co's value of 9.63 is 23.4% below this benchmark. Historically, Northeast Pharmaceutical Group Co's own Interest Coverage has ranged from 1.34 to 10.28 over the past decade. While the company's 10-year median is 3.21 vs. the industry median of 12.58, Northeast Pharmaceutical Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.58, based on 678 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Northeast Pharmaceutical Group Co's current Interest Coverage of 9.63 is 23.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Northeast Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Northeast Pharmaceutical Group Co's current Interest Coverage is 9.63, which is 200% above median its own 10-year median of 3.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Northeast Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Northeast Pharmaceutical Group Co (SZSE:000597) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥4.21, compared to a current price of ¥4.74 — trading 12.6% above its estimated fair value. The current Interest Coverage is 9.63, which is 200% above median its 10-year median of 3.21 and 23.4% below the Drug Manufacturers industry median of 12.58. Northeast Pharmaceutical Group Co's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Northeast Pharmaceutical Group Co (SZSE:000597), the current Interest Coverage is 9.63 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Northeast Pharmaceutical Group Co (SZSE:000597) Overvalued in 2026?
Based on GuruFocus' analysis, Northeast Pharmaceutical Group Co stock appears to be overvalued.
The current stock price of ¥4.74 is trading 12.6% above its estimated GF Value™ of ¥4.21.
GuruFocus considers Northeast Pharmaceutical Group Co to be Modestly Overvalued.
Key valuation signals for SZSE:000597:
Interest Coverage: 9.63 (200% above median its 10-year median of 3.21)
GF Value™: ¥4.21 vs. price of ¥4.74 (12.6% above fair value)
Industry Position: 23.4% below the Drug Manufacturers median (#385 of 678)
No single metric tells the full story. See the SZSE:000597 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Northeast Pharmaceutical Group Co Ltd is engaged in the production and distribution of ammonium phosphate, sulfuric acid, cement, compound fertilizer, bromine, raw salt, and diammonium phosphate.
62GF Score
Get the complete analysis for SZSE:000597
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:000597 has been successfully added to your 
